Inventor
James T. Link
Inventor
Stanford, CA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds21%
A61KPreparations for medical, dental or toiletry purposes16%
C07JSteroids3%
PatentTitleYear
9,464,072'Treatment of central nervous system disorders'20169,290,444'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20169,133,145'Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20158,993,632'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20158,940,902'Treatment of central nervous system disorders'20158,716,345'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20148,415,354'Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20138,372,841'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20138,314,270'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20128,198,331'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20127,880,001'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme'20117,855,308'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme'20107,737,137'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme'20107,528,282'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20097,521,439'Glucocorticoid receptor ligands for the treatment of metabolic disorders'20097,511,175'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20097,435,833'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme'20087,217,838'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'20077,141,559'Glucocorticoid receptor ligands for the treatment of metabolic disorders'2006RE039197'Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds'20066,878,700'Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds'20056,583,180'Glucocorticoid receptor modulators'20036,521,619'Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents'20036,110,922'Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2013Patents assigned to ABBOTT LAB (16)· patent assignee history
2000–2011Based in Evanston, IL, US· patent location history
2003Based in Chicago, IL, US· patent location history
2010–2016Based in Stanford, CA, US· patent location history
2012–2015Patents assigned to LINK JAMES T (7)· patent assignee history
2012–2015Patents assigned to SHUAI QI (6)· patent assignee history
2012–2015Patents assigned to SORENSEN BRYAN K (6)· patent assignee history
2013Based in Standford, CA, US· patent location history
2014–2016Patents assigned to ABBVIE INC (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 16 | 2000–2013 |
| LINK JAMES Tself | 7 | 2012–2015 |
| ABBVIE INC | 6 | 2014–2016 |
| SHUAI QI | 6 | 2012–2015 |
| SORENSEN BRYAN K | 6 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Stanford, California, US | 11 | 2010–2016 |
| Evanston, Illinois, US | 11 | 2000–2011 |
| Standford, California, US | 1 | 2013 |
| Chicago, Illinois, US | 1 | 2003 |